"54575-230-30" National Drug Code (NDC)

Rinkel Mold Mix C 30 mL in 1 VIAL, MULTI-DOSE (54575-230-30)
(Allergy Laboratories, Inc.)

NDC Code54575-230-30
Package Description30 mL in 1 VIAL, MULTI-DOSE (54575-230-30)
Product NDC54575-230
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameRinkel Mold Mix C
Non-Proprietary NameAbsidia Capillata And Acrothecium Robustum And Microsporum Audouinii And Microsporum Canis And Apiospora Montagnei And Phycomyces Blakesleeanus And Sporotrichum Pruinosum And Stachybotrys Chartarum An
Dosage FormINJECTION, SOLUTION
UsagePERCUTANEOUS; SUBCUTANEOUS
Start Marketing Date19671207
Marketing Category NameBLA
Application NumberBLA101376
ManufacturerAllergy Laboratories, Inc.
Substance NameABSIDIA CAPILLATA; ACROTHECIUM ROBUSTUM; MICROSPORUM AUDOUINII; MICROSPORUM CANIS; APIOSPORA MONTAGNEI; PHYCOMYCES BLAKESLEEANUS; SPOROTRICHUM PRUINOSUM; STACHYBOTRYS CHARTARUM; SYNCEPHALASTRUM RACEMOSUM; TETRACOCCOSPORIUM PAXIANUM; VERTICILLIUM ALBO-ATRUM; THERMOMYCES LANUGINOSUS; TRICHOSPORON CUTANEUM
Strength.076; .077; .077; .077; .077; .077; .077; .077; .077; .077; .077; .077; .077
Strength Unitg/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL
Pharmacy ClassesNon-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/54575-230-30